Dr Jinglei Yu

Dr Jinglei Yu has extensive expertise in mass spectrometry analysis with a PhD and several years of experience in this field. She has been working in the Advanced Mass Spectrometry Facility at the School of Biosciences since 2015 running the proteomics service.



  1. C. Rosting, J. Yu and H.J. Cooper. High Field Asymmetric Waveform Ion Mobility Spectrometry in Nontargeted Bottom-up Proteomics of Dried Blood Spots. Journal of Proteome Research, 1997-2004.


  1. M.J. Armstrong, D. Hull, K. Guo, D. Barton, J. Yu, J.W. Tomlinson and P. Newsome. Effect of liraglutide on adipose insulin resistance and hepatic de-novo lipogenesis in non-alcoholic steatohepatitis: substudy of a phase 2, randomised placebo-controlled trial. The Lancet.
  2. M.J. Armstrong, J.M. Haslehurst, D. Hull, K. Guo, S. Borrows, J. Yu, S.C. Gough, P.N. Newsome and J.W. Tomlinson. Abdominal Subcutaneous Adipose Tissue Insulin resistance and Lipolysis in patients with Non-alcoholic Steatohepatitis. Diabetes, Obesity and Metabolism, 651-660.


  1. J.M. Haslehurst, L.L. Gathercole, M. Nasiri, M.J. Armstrong, S. Borrows, J. Yu, A.J.M. Wagenmakers, P.M. Stewart and J.W. Tomlinson. Glucocorticoids Fail to Cause Insulin Resistance in Human Subcutaneous Adipose Tissue In Vivo. The Journal of Clinical Endocrinology and Metabolism, 1631-1640.


  1. J. Yu, M.J.I. Paine, J.D. Marecham, C.A. Kemp, C.J. Ward, S. Brown, M.J. Sutcliffe, G.C.K. Roberts, E.M. Rankin and C.R. Wolf. In silico prediction of drug binding to CYP2D6: Identification of a new metabolite of metoclopramide. Drug Metabolism and Disposition, 1386-1392.
  2. J.D. Marecham, J. Yu, S. Brown, I. Kapelioukh, E.M. Rankin, C.R. Wolf, G.C.K. Roberts, M.J.I. Paine and M.J. Sutcliffe. In silico and in vitro screening for inhibition of cytochrome P450CYP3A4 by comedications commonly used by patients with cancer. Drug Metabolism and Disposition, 534-538.